Literature DB >> 12011018

Dissemination of the phage-associated novel superantigen gene speL in recent invasive and noninvasive Streptococcus pyogenes M3/T3 isolates in Japan.

Tadayoshi Ikebe1, Akihito Wada, Yoshishige Inagaki, Kumiko Sugama, Rieko Suzuki, Daisuke Tanaka, Aki Tamaru, Yoshihiro Fujinaga, Yoshiaki Abe, Yoshikata Shimizu, Haruo Watanabe.   

Abstract

In Japan, more than 10% of streptococcal toxic shock-like syndrome (TSLS) cases have been caused by Streptococcus pyogenes M3/T3 isolates since the first reported TSLS case in 1992. Most M3/T3 isolates from TSLS or severe invasive infection cases during 1992 to 2001 and those from noninvasive cases during this period are indistinguishable in pulsed-field gel electropherograms. The longest fragments of these recent isolates were 300 kb in size, whereas those of isolates recovered during or before 1973 were 260 kb in size. These 260- and 300-kb fragments hybridized to each other, suggesting the acquisition of an about 40-kb fragment by the recent isolates. The whole part of the acquired fragment was cloned from the first Japanese TSLS isolate, NIH1, and its nucleotide sequence was determined. The 41,796-bp fragment is temperate phage phiNIH1.1, containing a new superantigen gene speL near its right attachment site. The C-terminal part of the deduced amino acid sequence of speL has 48 and 46% similarity with well-characterized erythrogenic toxin SpeC and the most potent superantigen, SmeZ-2, respectively. None of 10 T3 isolates recovered during or before 1973 has speL, whereas all of 18 M3/T3 isolates recovered during or after 1992 and, surprisingly, Streptococcus equi subsp. equi ATCC 9527 do have this gene. Though plaques could not be obtained from phiNIH1.1, its DNA became detectable from the phage particle fraction upon mitomycin C induction, showing that this phage is not defective. A horizontal transfer of the phage carrying speL may explain the observed change in M3/T3 S. pyogenes isolates in Japan.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12011018      PMCID: PMC128029          DOI: 10.1128/IAI.70.6.3227-3233.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Genomic differences in Streptococcus pyogenes serotype M3 between recent isolates associated with toxic shock-like syndrome and past clinical isolates.

Authors:  Y Inagaki; F Myouga; H Kawabata; S Yamai; H Watanabe
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

2.  Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two new superantigens from Streptococcus pyogenes.

Authors:  V L Arcus; T Proft; J A Sigrell; H M Baker; J D Fraser; E N Baker
Journal:  J Mol Biol       Date:  2000-05-26       Impact factor: 5.469

3.  Epidemiological and clinical aspects of invasive group A streptococcal infections and the streptococcal toxic shock syndrome.

Authors:  B K Eriksson; J Andersson; S E Holm; M Norgren
Journal:  Clin Infect Dis       Date:  1998-12       Impact factor: 9.079

4.  Analysis of a second bacteriophage hyaluronidase gene from Streptococcus pyogenes: evidence for a third hyaluronidase involved in extracellular enzymatic activity.

Authors:  W L Hynes; L Hancock; J J Ferretti
Journal:  Infect Immun       Date:  1995-08       Impact factor: 3.441

5.  [Case report of toxic shock-like syndrome due to group A streptococcal infection].

Authors:  Y Shimizu; A Ohymama; K Kasama; M Miyazaki; K Ooe; Y Ookochi
Journal:  Kansenshogaku Zasshi       Date:  1993-03

6.  Complete genome sequence of an M1 strain of Streptococcus pyogenes.

Authors:  J J Ferretti; W M McShan; D Ajdic; D J Savic; G Savic; K Lyon; C Primeaux; S Sezate; A N Suvorov; S Kenton; H S Lai; S P Lin; Y Qian; H G Jia; F Z Najar; Q Ren; H Zhu; L Song; J White; X Yuan; S W Clifton; B A Roe; R McLaughlin
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

7.  Invasive group A streptococcal infections in Ontario, Canada. Ontario Group A Streptococcal Study Group.

Authors:  H D Davies; A McGeer; B Schwartz; K Green; D Cann; A E Simor; D E Low
Journal:  N Engl J Med       Date:  1996-08-22       Impact factor: 91.245

8.  The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study.

Authors:  C W Hoge; B Schwartz; D F Talkington; R F Breiman; E M MacNeill; S J Englender
Journal:  JAMA       Date:  1993-01-20       Impact factor: 56.272

9.  Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A.

Authors:  D L Stevens; M H Tanner; J Winship; R Swarts; K M Ries; P M Schlievert; E Kaplan
Journal:  N Engl J Med       Date:  1989-07-06       Impact factor: 91.245

10.  ANTIGENIC PROPERTIES OF THE TYPE-SPECIFIC SUBSTANCE DERIVED FROM GROUP A HEMOLYTIC STREPTOCOCCI.

Authors:  G K Hirst; R C Lancefield
Journal:  J Exp Med       Date:  1939-02-28       Impact factor: 14.307

View more
  27 in total

1.  Integration and distribution of Lactobacillus johnsonii prophages.

Authors:  Marco Ventura; Carlos Canchaya; David Pridmore; Bernard Berger; Harald Brüssow
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

Review 2.  Bacterial superantigens.

Authors:  T Proft; J D Fraser
Journal:  Clin Exp Immunol       Date:  2003-09       Impact factor: 4.330

Review 3.  Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion.

Authors:  Harald Brüssow; Carlos Canchaya; Wolf-Dietrich Hardt
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

4.  Antimicrobial susceptibility survey of Streptococcus pyogenes isolated in Japan from patients with severe invasive group A streptococcal infections.

Authors:  Tadayoshi Ikebe; Kyoko Hirasawa; Rieko Suzuki; Junko Isobe; Daisuke Tanaka; Chihiro Katsukawa; Ryuji Kawahara; Masaaki Tomita; Kikuyo Ogata; Miyoko Endoh; Rumi Okuno; Haruo Watanabe
Journal:  Antimicrob Agents Chemother       Date:  2005-02       Impact factor: 5.191

5.  Genome organization and molecular analysis of the temperate bacteriophage MM1 of Streptococcus pneumoniae.

Authors:  Virginia Obregón; José L García; Ernesto García; Rubens López; Pedro García
Journal:  J Bacteriol       Date:  2003-04       Impact factor: 3.490

6.  Comparative genomic analysis of ten Streptococcus pneumoniae temperate bacteriophages.

Authors:  Patricia Romero; Nicholas J Croucher; N Luisa Hiller; Fen Z Hu; Garth D Ehrlich; Stephen D Bentley; Ernesto García; Tim J Mitchell
Journal:  J Bacteriol       Date:  2009-06-05       Impact factor: 3.490

Review 7.  Prophage genomics.

Authors:  Carlos Canchaya; Caroline Proux; Ghislain Fournous; Anne Bruttin; Harald Brüssow
Journal:  Microbiol Mol Biol Rev       Date:  2003-06       Impact factor: 11.056

8.  Streptococcal collagen-like protein A and general stress protein 24 are immunomodulating virulence factors of group A Streptococcus.

Authors:  James A Tsatsaronis; Andrew Hollands; Jason N Cole; Peter G Maamary; Christine M Gillen; Nouri L Ben Zakour; Malak Kotb; Victor Nizet; Scott A Beatson; Mark J Walker; Martina L Sanderson-Smith
Journal:  FASEB J       Date:  2013-03-26       Impact factor: 5.191

9.  Highly frequent mutations in negative regulators of multiple virulence genes in group A streptococcal toxic shock syndrome isolates.

Authors:  Tadayoshi Ikebe; Manabu Ato; Takayuki Matsumura; Hideki Hasegawa; Tetsutaro Sata; Kazuo Kobayashi; Haruo Watanabe
Journal:  PLoS Pathog       Date:  2010-04-01       Impact factor: 6.823

10.  Genetic and phenotypic diversity in Burkholderia: contributions by prophage and phage-like elements.

Authors:  Catherine M Ronning; Liliana Losada; Lauren Brinkac; Jason Inman; Ricky L Ulrich; Mark Schell; William C Nierman; David Deshazer
Journal:  BMC Microbiol       Date:  2010-07-28       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.